Century Therapeutics Ownership | Who Owns Century Therapeutics?


OverviewForecastRevenueFinancialsChart

Century Therapeutics Ownership Summary


Century Therapeutics is owned by 26.31% institutional investors, 24.85% insiders, and 48.84% retail investors. Boxer capital is the largest institutional shareholder, holding 7.87% of IPSC shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.49% of its assets in Century Therapeutics shares.

IPSC Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCentury Therapeutics26.31%24.85%48.84%
SectorHealthcare Stocks 492.67%11.09%-403.76%
IndustryBiotech Stocks 295.31%11.22%-206.53%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Boxer capital4.90M7.87%$12.50M
Blackrock2.90M4.65%$7.38M
Bain capital life sciences investors3.54M4.10%$1.76M
Renaissance2.59M3.00%$1.29M
Vanguard group2.10M2.44%$1.05M
Dafna capital management1.70M1.98%$848.71K
Casdin capital1.23M1.42%$611.64K
Syncona portfolio1.21M1.41%$604.10K
Two sigma investments, lp911.45K1.06%$453.90K
Tang capital management900.00K1.04%$448.20K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Syncona portfolio1.21M2.18%$604.10K
Boxer capital4.90M0.66%$12.50M
Superstring capital management lp462.96K0.23%$230.56K
Dafna capital management1.70M0.21%$848.71K
Bain capital life sciences investors3.54M0.12%$1.76M
Casdin capital1.23M0.05%$611.64K
Gsa capital partners llp603.48K0.03%$301.00K
Parametrica management27.84K0.02%$13.86K
Tang capital management900.00K0.02%$448.20K
Harbourvest partners29.02K0.01%$14.45K

Top Buyers

HolderShares% AssetsChange
Boxer capital4.90M0.66%3.15M
Blackrock2.90M0.00%1.40M
Renaissance2.59M0.00%564.40K
Two sigma advisers, lp857.60K0.00%490.50K
Acadian asset management719.81K0.00%412.71K

Top Sellers

HolderShares% AssetsChange
Vr adviser---2.50M
Bain capital life sciences investors3.54M0.12%-1.87M
Millennium management---1.61M
Adage capital partners gp---1.32M
Avidity partners management lp---1.22M

New Positions

HolderShares% AssetsChangeValue
Lazard asset management62.95K-62.95K$35.00K
Susquehanna group, llp33.40K-33.40K$33.73K
Abel hall17.58K0.00%17.58K$9.82K
Srs capital advisors99.00-99.00$49.00
Optiver b.v.32.00-32.00$16.00

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-6.00
Capital performance advisors llp-12.00
Gamma investing-131.00
True wealth design-266.00
Advisor group-360.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202566-4.35%22,628,552-20.19%262.42%3760.87%20-31.03%
Mar 31, 202570-5.41%29,566,395-18.77%341.86%23-48.89%29190.00%
Dec 31, 2024748.82%36,399,688-8.20%421.96%4441.94%10-37.50%
Sep 30, 20246811.48%39,649,236-1.17%461.96%31-20.51%1633.33%
Jun 30, 202460-10.45%40,117,75873.62%644.24%3939.29%11-50.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.29M1.49%-28.12K
Fidelity Growth Compy Commingled Pl O1.22M1.45%-96.60K
Syncona Ord1.21M1.43%212.28K
Vanguard Institutional Extnd Mkt Idx Tr539.66K0.63%-245.91K
Fidelity Small Cap Index480.13K0.56%-
State St Russell Sm/Mid Cp® Indx NL Cl C366.83K0.43%-
State St Russell Sm/Mid Cp® Indx SL Cl I366.83K0.43%-
Federated Hermes Kaufmann Growth267.75K0.32%-
Federated Hermes Kaufmann R267.75K0.32%-
Vanguard Russell 2000 ETF229.84K0.27%2.12K

Recent Insider Transactions


DateNameRoleActivityValue
Nov 03, 2025Carr Douglas SVP Finance & OperationsSell$171.11
Sep 08, 2025Carr Douglas SVP Finance & OperationsSell$131.50
Sep 08, 2025Pfeiffenberger Brent President and CEOSell$244.00
Sep 08, 2025Russotti Gregory See RemarksSell$269.50
Aug 04, 2025Carr Douglas SVP Finance & OperationsSell$158.06

Insider Transactions Trends


DateBuySell
2025 Q4-1
2025 Q3-4
2025 Q2-7
2025 Q1-7
2024 Q4-2

IPSC Ownership FAQ


Who Owns Century Therapeutics?

Century Therapeutics shareholders are primarily institutional investors at 26.31%, followed by 24.85% insiders and 48.84% retail investors. The average institutional ownership in Century Therapeutics's industry, Biotech Stocks , is 295.31%, which Century Therapeutics falls below.

Who owns the most shares of Century Therapeutics?

Century Therapeutics’s largest shareholders are Boxer capital (4.9M shares, 7.87%), Blackrock (2.9M shares, 4.65%), and Bain capital life sciences investors (3.54M shares, 4.10%). Together, they hold 16.62% of Century Therapeutics’s total shares outstanding.

Does Blackrock own Century Therapeutics?

Yes, BlackRock owns 4.65% of Century Therapeutics, totaling 2.9M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 7.38M$. In the last quarter, BlackRock increased its holdings by 1.4M shares, a 93.28% change.

Who is Century Therapeutics’s biggest shareholder by percentage of total assets invested?

Syncona portfolio is Century Therapeutics’s biggest shareholder by percentage of total assets invested, with 2.18% of its assets in 1.21M Century Therapeutics shares, valued at 604.1K$.

Who is the top mutual fund holder of Century Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Century Therapeutics shares, with 1.49% of its total shares outstanding invested in 1.29M Century Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools